Fei Xiong

发表

Emodin Ameliorates Renal Damage and Podocyte Injury in a Rat Model of Diabetic Nephropathy via Regulating AMPK/mTOR-Mediated Autophagy Signaling Pathway

Hong Liu, Wenqiang Yang, Quan Wang, 2021, Diabetes, metabolic syndrome and obesity : targets and therapy.

Current pattern of Chinese dialysis units: a cohort study in a representative sample of units.

C. Mei, F. Hou, D. Xie, 2012, Chinese medical journal.

The treatment of paraprotein-related kidney disease

C. Hutchison, Fei Xiong, P. Mollee, 2017, Current opinion in nephrology and hypertension.

Serum and Tissue Levels of Advanced Glycation End Products and Risk of Mortality in Patients on Maintenance Hemodialysis

C. Mei, Shiren Sun, Jianghua Chen, 2021, American Journal of Nephrology.

Burden of kidney disease among patients with peritoneal dialysis versus conventional in-centre haemodialysis: A randomised, non-inferiority trial

Xueqing Yu, Menghua Chen, Z. Ni, 2022, Peritoneal dialysis international : journal of the International Society for Peritoneal Dialysis.

Recent advances of mTOR inhibitors use in autosomal dominant polycystic kidney disease: is the road still open?

Shuang Wei, Fei Xiong, P. Kou, 2018, Current medicinal chemistry.

Development and Validation of Residual Kidney Function Estimating Equations in Dialysis Patients

H. Tighiouart, A. Levey, F. Dekker, 2019, Kidney medicine.

Astragaloside IV attenuates proteinuria in streptozotocin-induced diabetic nephropathy via the inhibition of endoplasmic reticulum stress

Xiaohui Xie, Fei Xiong, Zengsi Wang, 2015, BMC Nephrology.

Astragaloside IV Attenuates proteinuria in Streptozotocin-Induced Diabetic Nephropathy through inhibition ER Stress

Fei Xiong, Zengsi Wang, Dan Chen, 2014 .

An analysis on the clinical features of maintenance hemodialysis patients with coronavirus disease 2019: A single center study

Sheng Wan, Fei Xiong, Yuting Song, 2022, Integrative Medicine in Nephrology and Andrology.

Changes before and after COVID-19 pandemic on the personal hygiene behaviors and incidence of peritonitis in peritoneal-dialysis patients: a multi-center retrospective study

Yanglin Hu, Sheng Wan, Fei Xiong, 2021, International Urology and Nephrology.

Association between medical insurance type and survival in patients undergoing peritoneal dialysis

Yanmin Zhang, Sheng Wan, Fei Xiong, 2015, BMC Nephrology.

Exploring Mechanisms by Which Danggui Buxue Decoction Regulates Inflammation and Improves Renal Anemia Based on Network Pharmacology

Fei Xiong, D. Mao, Can Tu, 2022, Natural Product Communications.

Accumulation of tissue advanced glycation end products correlated with glucose exposure dose and associated with cardiovascular morbidity in patients on peritoneal dialysis.

X. Yang, C. Mei, T. Miyata, 2012, Atherosclerosis.

Management of Maintenance Hemodialysis Patients under the Coronavirus Disease Pandemic

Fei Xiong, Can Tu, 2022, Integrative Medicine in Nephrology and Andrology.

COVID-19 in Peritoneal Dialysis Patients.

Hui Tang, Chun Zhang, Fei Xiong, 2020, Clinical journal of the American Society of Nephrology : CJASN.

Clinical Features and Outcomes of COVID-19 Patients with Acute Kidney Injury and Acute Kidney Injury on Chronic Kidney Disease

Fei Xiong, Jing Xiong, Yuanyuan Zhang, 2022, Aging and disease.

Patients with Chronic Kidney Disease Have Higher Acute Kidney Injury Morbidity than those without after SARS-CoV-2 Infection

Yanglin Hu, Fei Xiong, Yuting Song, 2021, Integrative Medicine in Nephrology and Andrology.

Serum Uromodulin and All-Cause Mortality in Peritoneal Dialysis Patients: A Chinese Cohort Study

H. Zhang, A. Levey, L. Inker, 2022, Kidney medicine.

Clinical characteristics of deceased hemodialysis patients affected by COVID-19

Fei Xiong, Can Tu, Dan Chen, 2021, International Urology and Nephrology.

Clinical Characteristics of and Medical Interventions for COVID-19 in Hemodialysis Patients in Wuhan, China.

Hui Tang, Chun Zhang, Jing Liu, 2020, Journal of the American Society of Nephrology : JASN.

Accumulation of circulating advanced oxidation protein products is an independent risk factor for ischaemic heart disease in maintenance haemodialysis patients

C. Mei, Shiren Sun, Xueqing Yu, 2012, Nephrology.

Risk factors for the mortality of hemodialysis patients with COVID‐19: A multicenter study from the overall hemodialysis population in Wuhan

Hui Tang, Chun Zhang, Y. Qiu, 2021, Seminars in dialysis.

Impact of chronic kidney disease on mortality and cardiovascular outcomes after acute coronary syndrome: A nationwide data linkage study (ANZACS‐QI 44)

A. Kerr, K. Poppe, M. Legget, 2020, Nephrology.

MiR-194 targets Runx1/Akt pathway to reduce renal fibrosis in mice with unilateral ureteral obstruction

Sheng Wan, Fei Xiong, Can Tu, 2020, International Urology and Nephrology.

Association between serum advanced oxidation protein products and mortality risk in maintenance hemodialysis patients

Wei Zhou, C. Mei, Jianghua Chen, 2021, Journal of translational medicine.

Clinical characteristics and outcome of hemodialysis patients with COVID-19: a large cohort study in a single Chinese center

Fei Xiong, Rong Zou, Dan Chen, 2020, Renal failure.

China collaborative study on dialysis: a multi-centers cohort study on cardiovascular diseases in patients on maintenance dialysis

X. Yang, C. Mei, Shiren Sun, 2012, BMC Nephrology.

Kidney damage in COVID-19 patients with or without chronic kidney disease: Analysis of clinical characteristics and related risk factors

Yanglin Hu, Fei Xiong, D. Mao, 2020, Indian Journal of Experimental Biology.